Shionogi Articles
MHLW joins Japan's first P-PP to facilitate R&D of new health technologies for the developing world
8 April 2013
Mylan settles with Shionogi and Andrx over Fortamet; Merck & Co diagnostics deal with Luminex
14 March 2013
FDA approves Shionogi's Osphena for postmenopausal women experiencing pain during sex
27 February 2013
Revised terms for ViiV Healthcare and Shionogi HIV partnership
30 October 2012
Mylan in patent settlement with Shionogi over Orapred ODT
11 October 2012
Japanese approvals for Eylea, Tresiba, Seebri and Aimix
1 October 2012
Shionogi sets up new EU unit; posts 37% profit hike
31 January 2012
Shionogi completes new $247 million research facility
15 August 2011
Shionogi makes $185 million offer for China’s C&O Pharma; reports first-quarter results
2 August 2011
Sandoz expands strategic alliance with Nipro in Japan; Shionogi licenses drug to Ildong
14 July 2011
Mylan sued by Shionogi and CIMA over Orapred patent challenge
20 December 2010
Japanese regulator approves manufacture and marketing of Daiichi Sankyo/Biota’s flu drug Inavir
14 September 2010
France’s Stallergenes licenses two allergens to Japan’s Shionogi for up to 70 million euros
8 September 2010
ViiV Healthcare committed to Phase III development program for investigational once-daily HIV integrase inhibitor
22 July 2010
Leadership changes at Biogen Idec, Exelixis, Abbott, Pierre Fabre; Shionogi reorganizes in USA
2 July 2010
AstraZeneca gets wider US indications for Crestor; enters cancer drug development deal with UK charity
9 February 2010
Blockbuster status predicted for co-formulation of rilpivirine and Truvada with sales of over $2 billion in the HIV Drug Market by 2018
7 January 2010
Highlights of research presented at ICAAC
15 September 2009
Japan stock market week to June 1, 2009
3 June 2009
Takeda and Shionogi announce US acquisitions
28 May 2009
Shionogi set to buy Victory for $150M
19 May 2009
Japan stock market week to May 11, 2009
12 May 2009
Sciele and Plethora present PSD502 PE data
30 April 2009
Shionogi begins European Ph I testing of cancer drug
8 April 2009
Japan stock market week to April 6, 2009
7 April 2009
Japan stock market week to March 30, 2009
31 March 2009
Shionogi to launch peramivir in fiscal 2009
23 March 2009
OncoTherapy focuses on cancer vaccs
16 March 2009
Significant results for Shionogi obesity drug
2 March 2009
Japan stock market week to Feb 23, 2009
2 March 2009
Japan stock market week to Feb 16, 2009
23 February 2009
PrandoiMet launched in USA
16 February 2009
Pharma/biotech mergers and acquisitions in 2008
12 January 2009
Japan stock market week to Dec 8, 2008
15 December 2008
Japan stock market week to Dec 1, 2008
8 December 2008
Shionogi profit jumps 10% on Crestor sales
8 December 2008
Japan stock market week to Nov 24, 2008
24 November 2008
Plethora stock jumps 55% on study results
17 November 2008
Optimal thiazide dose sought in Japan
3 November 2008
Addrenex initiates Ph II ADX415 study
3 November 2008
Japan stock market week to Oct 20, 2008
27 October 2008
InterMune/Shionogi get Japanese IPF appro
27 October 2008
Shionogi completes acquisition of Sciele
20 October 2008
Stock Commentary - Europe - week to Oct 6, 2008
13 October 2008
Shionogi extends deal with MorphoSys
6 October 2008
Sciele's drooling drug meets Ph III endpoints
22 September 2008
Japan stock market week to Sept 1, 2008
8 September 2008
Shionogi buys US firm Sciele for $1.1B
8 September 2008
FDA delay for J&J's Doribax
1 September 2008
Japan stock market week to August 4, 2008
11 August 2008
Japan stock market week to July 21, 2008
28 July 2008
Galderma gains approval for acne drug in Japan
28 July 2008
Japan stock market week to June 30, 2008
7 July 2008
Shionogi's Crestor boosts fiscal 2007
2 June 2008
Japan stock market week to May 19, 2008
26 May 2008
Japan stock market week to Aril 21, 2008
28 April 2008
Shionogi names new president and chairman
7 April 2008
Japan stock market week to March 24, 2008
31 March 2008
Japan stock market week to Mar 3, 2008
10 March 2008
Shionogi close to US Ph II results on obesity drug
25 February 2008
Japan stock market week to Jan 28, 2008
4 February 2008
Japan stock market week toJan 14, 2008
21 January 2008
Japan stock market week to Nov 26, 2007
3 December 2007
InterMune acquires key pirfenidone patents
3 December 2007
Japan stock market week to Nov 19, 2007
26 November 2007
New indication in USA for AstraZeneca's Crestor
19 November 2007
Cobalt challenges Crestor patent
12 November 2007
J&J's doripenem fares well vs NP and VAP
1 October 2007
Crestor boosts Shionogi 1st-qtr fiscal sales 8.7%
6 August 2007
J&J submits MAA for doripenem to EMEA
30 July 2007
Headlines 25 years ago this week....
23 July 2007
- Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
- Proposal to list Roche's Neulastim and Actemra in New Zealand
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
